News

  • uMotif evolves leadership team with appointment of Steve Rosenberg as CEO

    Read More

  • uMotif adds eClinical industry veteran Steve Rosenberg to board of directors

    Read More

  • uMotif and VirTrial partner to further expand decentralized clinical trial capabilities

    Read More
  • AWS Case Study

    AWS Case Study: The benefits and efficiencies of building the uMotif platform on Amazon Web Services infrastructure

    Read More
  • On-Demand Webinar

    On-Demand Webinar: Powering Virtual Trials – In the Cloud

    Read More
  • Making Pharma More Digital

    Making Pharma More Digital – Learnings From Startups

    Read More
  • The motif, made up of 10 segments, enables participants to track 10 Covid-related symptoms: fatigue and muscle ache, nausea, dry cough, shortness of breath, fever, loss of taste/smell, runny nose, sore throat, diarrhoea, and headache. As well as tracking symptoms the app includes medication adherence questions so the doctors can keep track of which participants use the sinus rinse and mouth wash. In addition to the remote data capture the trial onboarding and instructions also needed to be virtual. Dr Khan and his team produced a Youtube video to educate and guide people through the necessary steps. Although a small team, they have demonstrated what can be achieved when starting a trial using a virtual and digitised design. The trial is due to run through August 2020 and the team are already seeing early signs of success. Results for patients, who have a low viral load, using both treatments have eradicated the virus within 48 hours. Hopefully this trial will open the door to preventing the transmission of Covid-19

    uMotif support NHS study in the fight against Covid-19

    Read More

  • uMotif raise £5 million to power decentralised clinical trials and get therapies to patients faster

    Read More

  • uMotif recognised as one of BusinessCloud’s top 100 Healthtech Pioneers

    Read More